Sartorius Stedim Biotech ...

PNK: SDMHF · Real-Time Price · USD
216.65
-3.35 (-1.52%)
At close: May 30, 2025, 3:33 PM

Sartorius Stedim Biotech S.A. Income Statement

Financials in EUR. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
2.78B 2.78B 3.49B 2.89B
Cost of Revenue
1.57B 1.54B 1.66B 1.33B
Gross Profit
1.21B 1.23B 1.83B 1.55B
Operating Income
370.6M 449.5M 995.2M 865.42M
Interest Income
18.9M 6.2M 500K 276K
Pretax Income
219.2M 401.1M 1.13B 646.72M
Net Income
175.1M 309.7M 876.1M 414.4M
Selling & General & Admin
648.5M 616.2M 601.2M 531.76M
Research & Development
144.1M 129.5M 132.4M 110.49M
Other Expenses
43.5M n/a 1.7M 1.75M
Operating Expenses
836.1M 770.9M 751.7M 670.02M
Interest Expense
149.6M 117M 18.6M 10.4M
Selling & Marketing Expenses
479.8M 449.1M 446.5M 405.65M
Cost & Expenses
2.41B 2.31B 2.41B 2B
Income Tax Expense
40.7M 89M 250.5M 232.41M
Shares Outstanding (Basic)
96.78M 92.16M 92.16M 92.18M
Shares Outstanding (Diluted)
96.78M 92.16M 92.16M 92.18M
EPS (Basic)
1.81 3.36 9.51 4.50
EPS (Diluted)
1.81 3.36 9.51 4.50
EBITDA
670.5M 755.7M 1.23B 798.7M
EBIT
368.8M 518.1M 1.15B 657.1M
Depreciation & Amortization
301.7M 237.6M 181.7M 141.56M